July 18, 2025
Akira Suemori/AP

STAT+ | FDA advisers say risks of GSK blood cancer drug outweigh benefits in surprise setback

Blenrep combos have won approval in the U.K. and Japan for multiple myeloma, but FDA advisers raised concerns about eye-related side effect.

By Andrew Joseph


Opinion: Oncologists need to see antimicrobial resistance as a cancer care delivery crisis

Without effective antibiotics, we’ll never fully reap the benefits of immunotherapies, precision medicines, and other recent advances in cancer care.

By Yehoda Martei


Federal judge reverses rule that would have removed medical debt from credit reports

Removing medical debts from the reports was expected to increase the credit scores of millions of families by an average of 20 points.

By Associated Press



Adobe

Opinion: Medical research participants deserve to be paid well

There is scant empirical evidence that offers of money alone distort clinical trial participants’ ability to accurately assess risk and benefits.

By Jake Eberts and Jill Fisher


More around STAT

From the STAT archive


Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Cancer Briefing? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.